Department of Respiratory Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishiku, Kitakyushu City, Fukuoka, 807-8555, Japan.
Department of Respiratory Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishiku, Kitakyushu City, Fukuoka, 807-8555, Japan.
Respir Investig. 2021 Nov;59(6):741-747. doi: 10.1016/j.resinv.2021.07.003. Epub 2021 Aug 14.
Recently, culture-independent molecular methods, such as DNA sequencing techniques targeting the 16S-ribosomal RNA (rRNA) gene and/or other housekeeping genes with Sanger method-based technologies, next generation sequencing (NGS), and metagenomic analysis, have been developed for detecting microorganisms in the human body; these can provide information on microbiomes of samples from individuals with or without infectious diseases. Determining the bacterial species is crucial in identifying causative bacteria of upper and lower respiratory tract infections, especially for Streptococcus species, but NGS analysis is often not precise enough to identify bacteria at the species level. This review briefly introduces previous observations of the microbiome of samples from various respiratory and other infections assessed using the clone library method with Sanger sequencing of the 16S-rRNA gene. On analysis of 16S-rRNA gene-sequence data of bronchoalveolar lavage fluid obtained from pneumonia lesions in patients with bacterial pneumonia and lung abscess, anaerobes are often detected in non-elderly patients with pneumonia, and the detection rate of Staphylococcus aureus in patients with hospital-acquired pneumonia is lower than that previously reported. Analysis of pleural effusion samples from patients with pleurisy indicated a more important role of anaerobes than previous believed. The other topics reviewed include microbiomes of nontuberculous mycobacteriosis and lower respiratory tract infections in children with permanent tracheostomy due to neuromuscular disorders, in nasal discharge, in bacterial vaginosis, in the intracystic fluid of postoperative maxillary cyst, and in bacterial conjunctivitis; urine microbiota in urethritis; fecal microbiota; and newly detected infectious organisms in the human respiratory tract.
最近,已经开发出了一些不依赖于文化的分子方法,例如针对 16S-核糖体 RNA(rRNA)基因和/或其他管家基因的 DNA 测序技术,基于 Sanger 方法的技术、下一代测序(NGS)和宏基因组分析,用于检测人体中的微生物;这些方法可以提供来自患有或不患有传染病的个体的样本的微生物组信息。确定细菌种类对于鉴定上呼吸道和下呼吸道感染的致病细菌至关重要,特别是对于链球菌属,但 NGS 分析通常不够精确,无法在物种水平上识别细菌。本综述简要介绍了使用 Sanger 测序 16S-rRNA 基因的克隆文库方法评估来自各种呼吸道和其他感染的样本的微生物组之前的观察结果。对细菌性肺炎和肺脓肿患者肺炎病变支气管肺泡灌洗液的 16S-rRNA 基因序列数据分析表明,非老年肺炎患者常检测到厌氧菌,医院获得性肺炎患者金黄色葡萄球菌的检出率低于先前报道。对胸膜炎患者胸腔积液样本的分析表明,厌氧菌的作用比以前认为的更为重要。综述的其他主题包括非结核分枝杆菌病和神经肌肉疾病导致永久性气管造口术的儿童下呼吸道感染、鼻分泌物、细菌性阴道炎、上颌窦囊肿术后囊内液、细菌性结膜炎的微生物组;尿道炎的尿微生物组;粪便微生物组;以及新发现的人类呼吸道传染性生物体。